new paper in NRDD

In this piece for Nature Reviews Drug Discovery, Nick Kapolka and I discuss the druggability of the understudied GPCR, hydroxycarboxylic acid receptor 3 (HCAR3), which we recently discovered is activated by the tryptophan pathway metabolite kynurenic acid, a potent immunomodulator. The full text can be found here:

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s